The DEFINITE trial ( 9 ) showed a strong trend toward ICD benefit over the standard-therapy group for non-ischemic cardiomyopathy.
← all excerpts
Application of ICD guidelines and indications in a community-based academic hospital: a case series-based discussion.
1
—
—